FIGURE 1

Continuous measure outcomes at pre- and FU-treatment for the student therapist and professional therapist groups, the time-by-group effect and ES
| Pre –M(SD) | FU -M(SD) | Time-by-group effect | Pre-FU ES | |
|---|---|---|---|---|
| ADIS CSR primary diagnosis | ||||
| ST | 6.33 (0.75) | 1.74 (2.31) | F1, 108 = 1.53,p= 0.22, | p< 0.01,g= 1.88 |
| PT | 6.09 (1.07) | 1.59 (2.49) | p< 0.01,g= 1.81 | |
| ADIS CSR all diagnoses | ||||
| ST | 4.60 (1.32) | 1.37 (1.22) | F1, 108 = 0.13,p= 0.72, | p< 0.01,g= 2.51 |
| PT | 5.32 (0.95) | 1.28 (1.32) | p< 0.01,g= 3.27 | |
| SCAS youth | ||||
| ST | 41.57 (16.93) | 20.91 (12.95) | F1, 108 = 1.47,p= 0.23, | p< 0.01,g= 1.30 |
| PT | 39.16 (18.06) | 16.70 (13.23) | p< 0.01,g= 1.33 | |
| SCAS-P mother | ||||
| ST | 43.72 (14.98) | 21.72 (11.53) | F1, 108 = 1.49,p= 0.22, | p< 0.01,g= 1.56 |
| PTa | 38.91 (15.79) | 19.79 (13.61) | p< 0.01,g= 1.26 | |
| SCAS-P father | ||||
| ST | 38.18 (15.33) | 18.70 (12.55) | F1, 102 = 0.00,p= 0.99, | p< 0.01,g= 1.34 |
| PT | 37.15 (13.80) | 18.72 (10.63) | p< 0.01,g= 1.42 | |
| CALIS youth | ||||
| ST | 15.10 (8.09) | 8.50 (8.21) | F1, 108 = 3.30,p= 0.07, | p< 0.01,g= 0.80 |
| PT | 11.90 (7.35) | 5.79 (6.07) | p< 0.01,g= 0.88 | |
| CALIS mother | ||||
| ST | 19.65 (6.80) | 10.13 (7.09) | F1, 108 = 1.70,p= 0.20, | p< 0.01,g= 1.35 |
| PT | 17.78 (7.20) | 8.80 (7.75) | p< 0.01,g= 1.18 | |
| CALIS father | ||||
| ST | 18.51 (6.93) | 8.83 (6.67) | F1, 102 = 0.41,p= 0.53, | p< 0.01,g= 1.40 |
| PT | 16.05 (6.84) | 10.00 (7.85) | p< 0.01,g= 0.80 | |
| CALIS-P mother | ||||
| ST | 13.13 (5.72) | 6.39 (5.12) | F1, 108 = 1.10,p= 0.30, | p< 0.01,g= 1.22 |
| PT | 11.07 (6.91) | 5.68 (6.83) | p< 0.01,g= 0.77 | |
| CALIS-P father | ||||
| ST | 10.16 (5.65) | 5.27 (5.10) | F1,102 = 2.25,p= 0.14, | p< 0.01,g= 0.89 |
| PT | 7.85 (6.09) | 4.65 (4.77) | p< 0.01,g= 0.56 | |
Reliable and clinical significant changes at post-treatment and 3-month follow-up on SCAS, for intention to treat sample
| SCAS Youth | SCAS-P Mother | SCAS-P Father | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ST (n= 54) | PT (n= 56) | Fisher’s | ST (n= 54) | PT (n= 56) | Fisher’s | ST (n= 51a) | PT (n= 53b) | Fisher’s | |
| Pre-treatment | |||||||||
| Over clinical cut-off | 75.9% (41) | 67.9% (38) | p= 0.40 | 90.7% (49) | 85.7% (48) | p= 0.56 | 78.4% (40) | 84.9% (45) | p= 0.45 |
| Post-treatment | |||||||||
| RC deterioration | 0% (0) | 0% (0) | - | 0% (0) | 0% (0) | - | 0% (0) | 1.9% (1) | p= 0.99 |
| RC improvement | 63.0% (34) | 67.9% (38) | p= 0.69 | 81.5% (44) | 69.6% (39) | p= 0.19 | 74.5% (38) | 71.7% (38) | p= 0.83 |
| RC but not CSC | 18.5% (10) | 19.6% (11) | p= 0.99 | 33.3% (18) | 12.5% (7) | p= 0.01* | 17.6% (9) | 32.1% (17) | p= 0.11 |
| CSC | 44.4% (24) | 48.2% (27) | p= 0.71 | 48.1% (26) | 57.1% (32) | p= 0.45 | 56.9% (29) | 41.5% (22) | p= 0.17 |
| Three-month follow-up | |||||||||
| RC deterioration | 0% (0) | 5.4% (3) | p= 0.24 | 5.6% (3) | 10.7% (6) | p= 0.49 | 7.8% (4) | 5.7% (3) | p= 0.71 |
| RC improvement | 63.0% (34) | 50.0% (28) | p= 0.18 | 77.8% (42) | 66.1% (37) | p= 0.21 | 66.7% (34) | 56.6% (30) | p= 0.32 |
| RC but not CSC | 3.7% (2) | 19.6% (11) | p= 0.02* | 14.8% (8) | 28.6% (16) | p= 0.11 | 21.6% (11) | 15.1% (8) | p= 0.45 |
| CSC | 59.3% (32) | 35.7% (20) | p= 0.02* | 68.5% (37) | 48.2% (27) | p= 0.04* | 52.9% (27) | 47.2% (25) | p= 0.70 |
Proportion of youths no longer meeting criteria for primary anxiety diagnosis and all anxiety diagnosis at post-treatment and follow-up
| ST group (n= 54) | PT group (n= 56) | Fischer’s | |
|---|---|---|---|
| Post-treatment | |||
| Primary diagnosis | 50.0% (27) | 66.1% (37) | p= 0.122 |
| All diagnosis | 25.9% (14) | 48.2% (27) | p= 0.019* |
| Follow up | |||
| Primary diagnosis | 74.1% (40) | 76.8% (43) | p= 0.826 |
| All diagnosis | 46.3% (25) | 58.9% (33) | p= 0.252 |
Demographic and diagnostic characteristics for youths in student therapist and professional therapist group
| Youths in ST group (n= 54) | Youths in PT group (n= 56) | |
|---|---|---|
| Mean age in years (SD) | 10.18 (1.46) | 11.82 (2.49) |
| Males (%) | 32 (59.3) | 25 (44.6) |
| On psychopharmacological medication | 3 (6.7) | 2 (4.5) |
| Primary diagnosis (%) | ||
| SAD | 24 (44.4) | 15 (26.8) |
| GAD | 15 (27.8) | 14 (25.0) |
| SoP | 7 (13.0) | 7 (12.5) |
| SP | 6 (11.1) | 12 (21.4) |
| OCD | 1 (1.9) | 4 (7.1) |
| AP without PD | 1 (1.9) | 4 (7.1) |
| CSR mean for primary diagnosis | 6.33 (0.75) | 6.09 (1.07) |
| CSR mean for all diagnosis | 4.60 (1.33) | 5.32 (0.95) |
| Comorbid diagnoses (%) | ||
| Anxiety disorders | 50 (92.6) | 47 (83.9) |
| Externalizing disorders | 6 (11.2) | 6 (10.7) |
| Mood disorder | 1 (1.9) | 4 (7.1) |
| Other | 4a(7.4) | 3a(5.4) |
| No comorbidity | 4 (7.4) | 9 (16.1) |
| Number of anxiety disorders per youth (M) | 2.36 | 2.10 |
Continuous measure outcomes at pre- and post-treatment for student therapist and professional therapist groups, the time-by-group effect and ES
| Pre –M(SD) | Post –M(SD) | Time-by-group effect | Pre-post ES | |
|---|---|---|---|---|
| ADIS CSR primary diagnosis | ||||
| ST | 6.33 (0.75) | 2.85 (2.41) | F1,108= 0.18,p= 0.72, | p< 0.001,g= 1.36 |
| PT | 6.09 (1.07) | 2.16 (2.59) | p< 0.001,g= 1.51 | |
| ADIS CSR all diagnoses | ||||
| ST | 4.60 (1.32) | 2.13 (1.36) | F1,108= 0.52,p= 0.47, | p< 0.001,g= 1.82 |
| PT | 5.32 (0.95) | 1.69 (1.53) | p< 0.001,g= 2.52 | |
| SCAS youth | ||||
| ST | 41.57 (16.93) | 24.13 (14.36) | F1,108= 0.80,p= 0.37, | p< 0.001,g= 1.08 |
| PT | 39.16 (18.06) | 21.57 (14.42) | p< 0.001,g= 1.03 | |
| SCAS-P mother | ||||
| ST | 43.72 (14.98) | 23.76 (11.90) | F1,108= 1.94,p= 0.27 | p< 0.001,g= 1.41 |
| PTa | 38.91 (15.79) | 22.25 (12.59) | p< 0.001,g= 1.12 | |
| SCAS-P father | ||||
| ST | 38.18 (15.33) | 22.55 (12.57) | F1,102= 0.00,p= 0.99, | p< 0.001,g= 1.07 |
| PT | 37.15 (13.80) | 23.56 (13.87) | p< 0.001,g= 0.97 | |
| CALIS youth | ||||
| ST | 15.10 (8.09) | 7.57 (6.40) | F1,108= 1.87,p= 0.17, | p< 0.001,g= 0.99 |
| PT | 11.90 (7.35) | 7.55 (6.46) | p< 0.001,g= 0.61 | |
| CALIS mother | ||||
| ST | 19.65 (6.80) | 12.06 (7.28) | F1,108= 1.89,p= 0.17, | p< 0.001,g= 1.06 |
| PT | 17.78 (7.20) | 10.61 (7.28) | p< 0.001,g= 0.98 | |
| CALIS father | ||||
| ST | 18.51 (6.93) | 11.90 (6.29) | F1,102= 1.96,p= 0.17, | p< 0.001,g= 0.98 |
| PT | 16.05 (6.84) | 10.96 (7.72) | p< 0.001,g= 0.68 | |
| CALIS-P mother | ||||
| ST | 13.13 (5.72) | 7.26 (5.66) | F1,108= 1.39,p= 0.24, | p< 0.001,g= 1.02 |
| PT | 11.07 (6.91) | 6.82 (6.28) | p< 0.001,g= 0.63 | |
| CALIS-P father | ||||
| ST | 10.16 (5.65) | 6.86 (4.63) | F1,102= 3.17,p= 0.08, | p< 0.001,g= 0.62 |
| PT | 7.85 (6.09) | 5.71 (5.46) | p< 0.001,g= 0.32 | |